Acute Motor Conduction Block Neuropathy After Initiation of Omalizumab: Case Report and Literature Review for Possible Causality
Background: Omalizumab is an established therapy for allergic conditions, yet its neurological effects remain underexplored compared to other biological agents. Case description: A 45-year-old male with asthma developed acute quadriparesis one week after receiving the first dose of omalizumab. Elect...
Saved in:
| Main Authors: | Hosna S. Elshony, Abdulaziz Al-Ghamdi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-09-01
|
| Series: | eNeurologicalSci |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405650224000194 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Omalizumab is ineffective in regulating proasthmatic serum cytokine and chemokine levels in nonresponders with high BMI
by: Agnes Yang, BS, et al.
Published: (2025-05-01) -
Lichen planus pemphigoides treated with a low dose of oral prednisolone and omalizumab
by: Yurie Matsuura, MD, et al.
Published: (2024-11-01) -
Omalizumab controls surface phenotypes of dendritic cells and monocytes in asthma
by: Agnes Yang, BS, et al.
Published: (2025-08-01) -
Specificity of recovery in acute motor axonal neuropathy with conduction blocks on the example of two clinical cases
by: D. A. Grishina, et al.
Published: (2020-12-01) -
Dual biological treatments in immune-mediated disorders: a single center experience
by: Oded Shamriz, et al.
Published: (2025-04-01)